GlassScriptPhysician profile
Fabian Corona
NPI 1821401886
$4,714.28
in general payments reported to CMS, 2019-2025
21 companies · $917 in 2025
The $917 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $529 · 2020: $1,288 · 2021: $602 · 2022: $300 · 2023: $248 · 2024: $831 · 2025: $917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,911 · Entertainment: $85.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,911.09 |
| Entertainment | $85.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,010.70 | 2020-2025 | Myday Contact Lens |
| Glaukos Corporation | $1,000.00 | 2020 | |
| Alcon Vision LLC | $577.87 | 2019-2025 | Total30, Precision 1, Clareon |
| Lombart Brothers, INC. | $402.28 | 2025 | Opd-III |
| Sight Sciences, INC. | $303.17 | 2020-2021 | |
| Johnson & Johnson Vision Care, INC. | $229.62 | 2019-2022 | |
| Optos, INC. | $201.90 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $201.34 | 2023-2024 | Infuse |
| Visioneering Technologies, INC. | $197.55 | 2019-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $149.13 | 2019-2021 | |
| Allergan, INC. | $109.96 | 2022 | |
| Lkc Technologies, INC. | $89.97 | 2024 | |
| Dompe US, INC. | $61.68 | 2025 | Oxervate |
| Stryker Corporation | $43.31 | 2019 | |
| Thea Pharma INC. | $22.81 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $22.10 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $21.24 | 2021 | |
| Oyster Point Pharma, INC. | $19.54 | 2024 | Tyrvaya |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Biotissue Holdings INC. | $16.22 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $14.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fabian Corona listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.